Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)
Author:
Funder
National Institute of Health Research
Cancer Research UK
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,Hematology
Reference46 articles.
1. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2007
2. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial;Zietman;JAMA,2005
3. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer;Al-Mamgani;Int J Radiat Oncol Biol Phys,2008
4. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial;Beckendorf;Int J Radiat Oncol Biol Phys,2011
5. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial;Pollack;Int J Radiat Oncol Biol Phys,2002
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer;Nature Cancer;2024-07-12
2. Target Volume Optimization for Localized Prostate Cancer;Practical Radiation Oncology;2024-07
3. Efficiency and Accuracy Evaluation of Multiple Diffusion‐Weighted MRI Techniques Across Different Scanners;Journal of Magnetic Resonance Imaging;2023-06-19
4. Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial;International Journal of Radiation Oncology*Biology*Physics;2023-02
5. Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy;Advances in Radiation Oncology;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3